Goodwin Biotechnology, Inc. is a fully integrated cGMP contract manufacturing organization (CMO) of monoclonal antibodies and recombinant proteins for preclinical and clinical trials. With over 15 years experience as an independent contract manufacturer, GBI has worked with companies of all sizes from small university spin-offs to major research institutes, government agencies and large established biopharmaceutical companies.
Latest News
>
May 2009 - AREVA Med LLC Selects Goodwin Biotechnology
Inc. As A Partner For Its New Cancer Treatment
>
January 2009 - Goodwin Biotechnology, Inc. Completes GMP Manufacturing of Neogenix Oncology, Inc. Monoclonal Antibody For Upcoming Clinical Trials
> July 2008 - Goodwin Biotechnology’s Manufactured Melanin-Binding Antibody Used In Successful Melanoma Trial
Upcoming events and Appearances
To schedule an appointment with a GBI representative at any of the following events, please contact:
David Fischer
Executive Vice President for Client Operations
Phone: 954.327.9613
Email: dfischer@goodwinbio.com
Join us at:
Society of Nuclear Medicine 2009 - Booth 827
June 13-17, 2009
Metro Toronto Convention Centre, 255 Front Street West,
Toronto, Canada
|
